Molecular insights into the Stereospecificity of Arginine in RNA tetraloop folding

25 January 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

One of the possible hypotheses for the homochirality of amino acids in the context of the origin of life is that only a particular stereoisomer provides preferential stability to RNA folding by acting as a chemical chaperon. This study probes into the molecular understanding of such preferential stability for a small GAAA RNA tetraloop in the presence of chiral arginine amino acids using a combination of umbrella sampling and parallel bias metadynamics involving five collective variables to tackle the multi-dimensional free energy landscape for faster, better, and more efficient estimation with controlled sampling. Our results show that the free energetic stability of RNA differs significantly in the presence of D- and L- arginine, giving rise to different un-folding rates. Interestingly, the folding rates are not altered. We show that the origin of the chirality difference in RNA folding–unfolding dynamics is due to the differences in configurational diversity of RNA by adopting different unnatural conformations accompanied by different binding modes of D-arginine and L-arginine towards the given RNA motif.

Keywords

Molecular Dynamics
Enhanced Sampling
Metadynamics

Supplementary materials

Title
Description
Actions
Title
Supplementary Information
Description
Text and figures discussing different choices of collective variables for RNA folding in the absence of amino acid, reweighted free energy surfaces with respect to other collective variables, and representation of edge interactions in the RNA folds.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.